Iressa vs Placebo as Maintenance Therapy in Locally Advanced NSCLC

PHASE3TerminatedINTERVENTIONAL
Enrollment

490

Participants

Timeline

Start Date

January 31, 2004

Study Completion Date

August 31, 2007

Conditions
Non Small Cell Lung Carcinoma
Interventions
DRUG

Iressa (Gefitinib)

Trial Locations (32)

Unknown

Research Site, Avellino

Research Site, Bergamo

Research Site, Bologna

Research Site, Cagliari

Research Site, Campobasso

Research Site, Catania

Research Site, Catanzaro

Research Site, Chieti

Research Site, Cosenza

Research Site, Della Fratte

Research Site, Emilia

Research Site, Fano

Research Site, Florence

Research Site, Forlì

Research Site, Frattamaggiore

Research Site, Livorno

Research Site, Messina

Research Site, Milan

Research Site, Napoli

Research Site, Novara

Research Site, Orbassano

Research Site, Padua

Research Site, Palermo

Research Site, Pavia

Research Site, Potenza

Research Site, Ravenna

Research Site, Rimini

Research Site, Roma

Research Site, San Giovanni Rotondo

Research Site, Sassari

Research Site, Taormina

Research Site, Venezia-Mestre

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY